Specialty pharmacy expands access to an innovative, steroid-free treatment NEW PROVIDENCE, NJ, UNITED STATES, March 3, 2025 /EINPresswire / -- ...

Chronic Obstructive Pulmonary disease (COPD) has been around for almost 205 years and is one of the most prevalent non-infectious diseases in our country. It is the 2nd leading cause of death and ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

Ahmedabad: Senores Pharmaceuticals Limited, through its wholly-owned subsidiary Senores Pharmaceuticals, Inc., USA, has ...

GSK plc has announced that the China National Medical Products Administration has accepted for review the new drug ...

Roflumilast is used for treatment to reduce the risk of Chronic Obstructive Pulmonary Disease (COPD) exacerbations in ...

Senores Pharmaceutical added 2.18% to Rs 546.15 after the company's wholly owned subsidiary, Senores Pharmaceuticals, Inc., USA has signed an agreement to acquire Roflumilast 250 mcg and 500 mcg ...

China NMPA accepts for review GSK’s Nucala NDA to treat patients with chronic obstructive pulmonary disease: London, UK Friday, February 21, 2025, 09:00 Hrs [IST] GSK plc announ ...

"The polymicrobial infection, which arose in a context of bronchiectasis and asthmatic bronchitis, and which required the use of antibiotic cortisone therapy, makes the therapeutic treatment more ...

The 88-year-old pope has been diagnosed with a polymicrobial respiratory tract infection, though no further details have been provided regarding the infection.

"The polymicrobial infection, which arose on a picture of bronchiectasis and asthmatic bronchitis, and which required the use of cortisone antibiotic therapy, makes therapeutic treatment more ...

"The polymicrobial infection, which arose on a picture of bronchiectasis and asthmatic bronchitis, and which required the use of cortisone antibiotic therapy, makes therapeutic treatment more ...